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Pituitary apoplexy is an uncommon condition and medical emergency that classically presents with abrupt onset of severe 
headache, nausea, fever, impaired level of consciousness, visual disturbances and a variable degree of ocular paresis. The 
constellation of signs, symptoms and cerebrospinal fluid findings in keeping with meningitis is considered a rare presentation 
of pituitary apoplexy and often leads to a misdiagnosis of infectious meningoencephalitis. We present the case of a 52 year 
old male admitted with a diabetic ketoacidosis who subsequently developed a severe headache with features of meningism. 
Haematological tests revealed an elevated white cell count and C-reactive protein, and lumbar puncture demonstrated a 
marked neutrophilic pleocytosis and elevated protein. Ceftriaxone was commenced for the presumptive diagnosis of bacterial 
meningitis, but resulted in no improvement in the patient’s condition and so imaging studies were performed which revealed 
the presence of an incidental pituitary macroadenoma with intra-lesional haemorrhage, thus providing the diagnosis of pituitary 
apoplexy. The patient recovered with conservative management consisting of hormonal replacement therapy and continues to 
follow up at our facility.
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Case study
A 52-year-old man with poorly controlled type 2 diabetes 
mellitus and hypertension presented with a three-day history of 
headaches, vomiting and a productive cough. The examination 
revealed the man to be obese, with acanthosis nigricans and a 
blood pressure of 147/97  mmHg, tachycardia of 91 beats per 
minute, but no pyrexia. The remainder of the examination was 
normal, with no features of meningism or focal neurological 
deficit. The finger-prick glucose result was 25 mmol/l. An arterial 
blood gas test revealed a high anion gap metabolic acidosis, 
with a pH of 7.25 (normal range 7.36–7.44), base excess of −14.7 
(normal range −2 to  +  2  mEq), and serum bicarbonate of 
18.6  mmol/l (normal range 23–29  mmol/l). Ketonuria (2+) and 
glycosuria (3+) were demonstrated following urine dipstick 
testing. Formal laboratory investigations at the time of admission 
revealed normal calcium, magnesium and phosphate levels, and 
normal liver function and cardiac enzymes. The full blood count, 
C-reactive protein (CRP), and urea and electrolyte results are 
presented in Table 1. A diagnosis of diabetic ketoacidosis (DKA) 
was made, and therapy was instituted according to local protocol.
The patient’s DKA responded rapidly to therapy, and had resolved 
by day 1 post admission. However, he then complained of marked 
worsening of his headaches. He had clinical signs of meningism 
with neck stiffness, photophobia and pyrexia. A lumbar puncture 
was performed. The results are shown in Table 2. Concomitantly, 
there was a marked increase in the CRP to 206 mg/dl. Bacterial 
meningitis was suspected, and ceftriaxone was initiated pending 
the cerebrospinal fluid (CSF) culture results. There was minimal 
improvement in his symptoms three days later. The CSF culture 
was negative, so a computed tomography brain scan was 
performed. It demonstrated a mass in the pituitary fossa 
Table 1: Laboratory findings for the patient on admission
Parameter Result Reference range
White cell count (× 109/l) 8.95 3.92–10.40
Haemoglobin (g/dl) 18.30 13.40–17.50
Platelets (× 109/l) 340.00 171.00–388.00
C-reactive protein (mg/l) < 10.00 < 10.00
Sodium (mmol/l) 130.00 136.00–145.00
Potassium (mmol/l) 4.00 3.50–5.10
Chloride (mmol/l) 91.00 98.00–107.00
Carbon dioxide (mmol/l) 26.00 23.00–29.00
Urea (mmol/l) 11.10 2.10–7.10
Creatinine (umol/l) 192.00 64.00–104.00
Haemoglobin A1c (%) 14.10
Table 2: The patient’s cerebrospinal fluid results










Unidentified cells (/µl) 0.00
Indian ink Negative
Gram stain No bacteria observed
Cryptococcal latex antigen test Negative
VDRL test Nonreactive
The page number in the footer is not for bibliographic referencingwww.tandfonline.com/oemd 39
4 Journal of Endocrinology, Metabolism and Diabetes of South Africa 2016; 21(1):1–4
measuring at least 1.2  cm × 1.8  cm. Hypodensity was seen, 
consistent with a recent haemorrhage. Subsequent magnetic 
resonance imaging confirmed the presence of a pituitary 
macroadenoma measuring 1.8 cm × 1.3 cm × 1.25 cm (Figure 1). A 
pituitary profile was performed, which confirmed hypopituitarism 
involving the thyrotropes, lactotropes, corticotropes, 
somatotropes and gonadotropes, with concomitant decreases in 
the effector hormones (Table 3). Visual field testing revealed 
bitemporal haemianopia. The patient was started on pituitary 
hormone supplementation, and completed a 10-day course of 
antibiotics. He was referred to the neurosurgical service and is 
awaiting resection of the tumour. He was stable on discharge and 
continues to follow-up at our outpatient clinic.
Discussion
First described by Bailey et al. in 1898 (though only named by 
Broughman et al. in 1950),1 pituitary apoplexy is a well-known, 
but uncommon, endocrine emergency involving haemorrhage or 
infarction into a pre-existing pituitary adenoma or rarely normal 
pituitary gland.2–4 It is classically characterised by the abrupt 
onset of visual field deficit, impaired visual acuity, headaches and 
nausea, and with or without associated endocrine abnormalities. 
However, the clinical manifestations may vary, depending on the 
predominating pathophysiological mechanism, i.e. tumour 
expansion, extravasation of the blood into the subarachnoid 
space, or partial or total destruction of the pituitary gland. 
Meningism, as a constellation of signs and symptoms mimicking 
bacterial meningitis, as occurred in our patient, is rare.2,4 
Secondary hypoadrenalism due to deficient adrenocorticotropic 
hormone and cortisol responses frequently occurs, and may 
result in an acute hypocortisolaemic crisis.5
Huang et al. reported on a case in 2009 involving a 57-year-old 
Taiwanese man who presented with fever and meningism, with 
CSF features of acute bacterial meningitis, who was unresponsive 
to empiric antibiotic therapy.6 Minor differences in presentation 
were also reported in similar patients in two subsequent cases by 
Oh et al. and Lee et al.2,3
Although well described in the literature, the symptom of 
meningeal irritation is not considered a classic feature of pituitary 
apoplexy.2,3 The pathophysiology behind this symptom complex 
involves leakage of blood into the subarachnoid space, which, in 
conjunction with the necrotic tissue in the pituitary itself, induces 
a cytokine response, resulting in meningeal irritation and the 
subsequent CSF picture, as previously described.2–4
Both medical and surgical intervention is necessary in the 
management of pituitary apoplexy. Medical management 
includes prompt glucocorticoid therapy to replace any cortisol 
deficiency, as well as the replacement of other hormones, as 
indicated, based on the laboratory testing. Such conservative 
therapy may be all that is required in mild disease. Surgical 
intervention is indicated in severe disease with neuro-ophthalmic 
signs or reduced level of consciousness,5 and involves drainage of 
the haemorrhage with removal of the tumour.2,3
Conclusion
This case demonstrates the occurrence of pituitary apoplexy 
presenting as bacterial meningitis. It reinforces the importance of 
including pituitary apoplexy in the differential diagnosis of 
infectious meningitis and subarachnoid haemorrhage in patients 
presenting with acute headaches associated with pyrexia, 
meningism and visual abnormalities.
Declaration – None.
References
1.  Brougham M, Heusner AP, Adams RD. Acute degenerative changes in 
adenomas of the pituitary body—with special reference to pituitary 
apoplexy. J Neurosurg. 1950;7(5):421–39.
2.  Lee Y-M, Lin S-D, Sia H-K, et al. Pituitary apoplexy mimicking infectious 
meningitis: a case report. Formos J Endocrin Metab. 2011;2(2):49–54.
3.  Oh K, Kim JH, Choi JW, et al. Pituitary apoplexy mimicking meningitis. 
Brain Tumour Res Treat. 2013;1(2):111–5.
4.  Jeon BC, Park YS, Oh HS, et al. Pituitary apoplexy complicated by 
chemical meningitis and cerebral infarction. J Korean Med Sci. 
2007;22(6):1085–9.
5.  Ranabir S, Baruah MP. Pituitary apoplexy. Indian J Endocrinol Metab. 
2011 Sep;15(Suppl 3):S188–96.
6.  Huang WY, Chien YY, Wu CL, et al. Pituitary adenoma apoplexy with 
initial presentation mimicking bacterial meningoencephalitis: a case 
report. Am J Emerg Med. 2009 May;27(4):517.e1–4.
Received: 17-08-2015 Accepted: 04-11-2015
Figure 1: T2-weighted coronal magnetic resonance imaging, 
demonstrating a pituitary mass measuring 1.3 cm × 1.8 cm × 1.25 cm, 
causing expansion of the sella turcica, with an area of haemorrhage 
(arrow).
Table 3: Results of the pituitary panel
Notes: ACTH: adrenocorticotropic hormone, FSH: follicle-stimulating hormone, 
FT4: free thyroxine, GH: growth hormone, IGF-1: insulin-like growth factor-1, LH: 
luteinising hormone, TSH: thyroid stimulating hormone
Parameter Result Reference range
Prolactin (µg/l) 2.10 2.10–17.70
Testosterone (nmol/l) < 0.70 4.50–26.60
FSH (IU/l) 4.00 1.40–18.10
LH (IU/l) 0.90 1.50–9.30
GH (µg/l) 0.20 0.00–3.00
IGF-1 (µg/l) 56.70 87.00–238.00
TSH (mIU/l) 0.56 0.35–5.50
FT4 (pmol/l) 10.90 11.50–22.70
Cortisol (nmol/l) 84.00 Morning: 145.00–619.00
ACTH (pmol/l) < 1.10 1.10–10.20
